Moderna CEO Stéphane Bancel defended the company's plans to raise the price of its Covid vaccine at a Senate hearing Wednesday, saying the move was necessary because its government funding will ...
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
As the demand for COVID vaccines decreases worldwide, Moderna is planning to release a RSV vaccine, pending U.S. approval.
Moderna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting efforts took hold and sales ...
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.
The U.S. Food & Drug Administration has given its full and final approval for the use of Moderna's 'Spikevax' Covid vaccine, the drugmaker said Monday. Moderna (MRNA) shares moved higher ...
Do you have questions surrounding COVID-19, the vaccine and impacts on our communities? ABC13 is committed to finding answers and connecting you with resources. Man deliberately gets 217 Covid ...
The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 vaccines developed by Pfizer and Moderna which target newer variants of the SARS-CoV-2 virus, it was announced ...
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Moderna says its updated coronavirus ...
Mar. 15, 2024 — Researchers identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why immune cells that most efficiently recognize pathogens ...